CEMIC at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
CEMIC brings 5 presentations to IDWeek 2026 in Washington. Its program centres on bloodstream infections and infection prevention in cancer and transplant patients. It covers how carbapenemase class affects mortality on ceftazidime-avibactam, isavuconazole versus posaconazole prophylaxis, and the timing of oral step-down for Staphylococcus aureus bacteremia.
| Organization | IDWeek 2026 Attendance |
|---|---|
CEMIC Buenos Aires, Argentina | |
Poster Thu Oct 22 12:15pm–1:30pm Impact of Carbapenemase Class on 30-Day Mortality in Enterobacterales Bacteremia Treated with Ceftazidime-Avibactam with or without Aztreonam Poster Fri Oct 23 12:15pm–1:30pm Pseudomonas aeruginosa and Stenotrophomonas maltophilia Bacteremia in Patients with Cancer and Hematopoietic Cell Transplantation: Clinical Characteristics and Impact of Multidrug Resistance on Mortality Poster Sat Oct 24 12:15pm–1:30pm Effectiveness and Safety of Isavuconazole Compared with Posaconazole as Primary Antifungal Prophylaxis in High-risk Neutropenic Patients with Hematologic Malignancies and Allogeneic Hematopoietic Cell Transplantation Poster Sat Oct 24 12:15pm–1:30pm Impact of Follow-Up Blood Cultures in Gram-Negative Bacilli Bacteremia: Open-Label Trial with Historical Controls Poster Sat Oct 24 12:15pm–1:30pm When to Switch? Association Between Timing of Oral Step-Down and Outcomes in Staphylococcus aureus Bacteremia |
Instantly find 20 buyers from CEMIC
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction